299 related articles for article (PubMed ID: 20686085)
1. In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae.
Elemam A; Rahimian J; Doymaz M
J Clin Microbiol; 2010 Oct; 48(10):3558-62. PubMed ID: 20686085
[TBL] [Abstract][Full Text] [Related]
2. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.
Bratu S; Tolaney P; Karumudi U; Quale J; Mooty M; Nichani S; Landman D
J Antimicrob Chemother; 2005 Jul; 56(1):128-32. PubMed ID: 15917285
[TBL] [Abstract][Full Text] [Related]
3. Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.
Tang HJ; Lai CC; Chen CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
J Microbiol Immunol Infect; 2019 Apr; 52(2):273-281. PubMed ID: 27133391
[TBL] [Abstract][Full Text] [Related]
4.
Huang D; Yu B; Diep JK; Sharma R; Dudley M; Monteiro J; Kaye KS; Pogue JM; Abboud CS; Rao GG
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438930
[TBL] [Abstract][Full Text] [Related]
5. Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae.
Pankey GA; Ashcraft DS
Diagn Microbiol Infect Dis; 2011 Aug; 70(4):561-4. PubMed ID: 21767715
[TBL] [Abstract][Full Text] [Related]
6. Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae.
Diep JK; Jacobs DM; Sharma R; Covelli J; Bowers DR; Russo TA; Rao GG
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872078
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the synergistic effect of eravacycline and tigecycline against carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae.
Huang YS; Yang JL; Wang JT; Sheng WH; Yang CJ; Chuang YC; Chang SC
J Infect Public Health; 2024 May; 17(5):929-937. PubMed ID: 38599013
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
[TBL] [Abstract][Full Text] [Related]
9. Activity of Ceftazidime-Avibactam Against Clinical Isolates of Klebsiella pneumoniae, Including KPC-Carrying Isolates, Endemic to New York City.
Manning N; Balabanian G; Rose M; Landman D; Quale J
Microb Drug Resist; 2018; 24(1):35-39. PubMed ID: 28590820
[TBL] [Abstract][Full Text] [Related]
10. Comparison of polymyxin B, tigecycline, cefepime, and meropenem MICs for KPC-producing Klebsiella pneumoniae by broth microdilution, Vitek 2, and Etest.
Lat A; Clock SA; Wu F; Whittier S; Della-Latta P; Fauntleroy K; Jenkins SG; Saiman L; Kubin CJ
J Clin Microbiol; 2011 May; 49(5):1795-8. PubMed ID: 21367993
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of carbapenemase-producing strains of Klebsiella pneumoniae and Escherichia coli to the direct antibacterial activity of NAB739 and to the synergistic activity of NAB7061 with rifampicin and clarithromycin.
Vaara M; Siikanen O; Apajalahti J; Frimodt-Møller N; Vaara T
J Antimicrob Chemother; 2010 May; 65(5):942-5. PubMed ID: 20167589
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
Galani I; Souli M; Nafplioti K; Adamou P; Karaiskos I; Giamarellou H; Antoniadou A;
Eur J Clin Microbiol Infect Dis; 2019 Jun; 38(6):1143-1150. PubMed ID: 30825054
[TBL] [Abstract][Full Text] [Related]
13. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing
Ojdana D; Gutowska A; Sacha P; Majewski P; Wieczorek P; Tryniszewska E
Microb Drug Resist; 2019 Nov; 25(9):1357-1364. PubMed ID: 31295055
[TBL] [Abstract][Full Text] [Related]
14. Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model.
Bulman ZP; Zhao M; Satlin MJ; Chen L; Kreiswirth BN; Walsh TJ; Nation RL; Li J; Tsuji BT
Int J Antimicrob Agents; 2018 Jul; 52(1):114-118. PubMed ID: 29486233
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of polymyxin susceptibility profile among KPC-producing Klebsiella pneumoniae using Etest and MicroScan WalkAway automated system.
Perez LR
APMIS; 2015 Nov; 123(11):951-4. PubMed ID: 26361367
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity evaluation and comparison of methods of susceptibility for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacter spp. isolates.
Rechenchoski DZ; Dambrozio AML; Vivan ACP; Schuroff PA; Burgos TDN; Pelisson M; Perugini MRE; Vespero EC
Braz J Microbiol; 2017; 48(3):509-514. PubMed ID: 28552659
[TBL] [Abstract][Full Text] [Related]
17. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae.
Tascini C; Tagliaferri E; Giani T; Leonildi A; Flammini S; Casini B; Lewis R; Ferranti S; Rossolini GM; Menichetti F
Antimicrob Agents Chemother; 2013 Aug; 57(8):3990-3. PubMed ID: 23752510
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.
Oliva A; Scorzolini L; Cipolla A; Mascellino MT; Cancelli F; Castaldi D; D'Abramo A; D'Agostino C; Russo G; Ciardi MR; Mastroianni CM; Vullo V
J Antimicrob Chemother; 2017 Jul; 72(7):1981-1984. PubMed ID: 28369424
[TBL] [Abstract][Full Text] [Related]
19. Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes.
Sharma R; Patel S; Abboud C; Diep J; Ly NS; Pogue JM; Kaye KS; Li J; Rao GG
Int J Antimicrob Agents; 2017 Feb; 49(2):224-232. PubMed ID: 28040408
[TBL] [Abstract][Full Text] [Related]
20. Study of
Zhang W; Guo Y; Yang Y; Dong D; Zheng Y; Zhu D; Hu F
Microb Drug Resist; 2020 Mar; 26(3):204-210. PubMed ID: 31553260
[No Abstract] [Full Text] [Related]
[Next] [New Search]